Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India · Delayed Price · Currency is INR 669.90
-4.40 (-0.65%)
Jul 31, 2026, 3:30 PM IST
Aarti Pharmalabs Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 18,194 | 18,194 | 21,151 | 18,526 | 19,452 | 11,999 |
Revenue Growth | -13.98% | -13.98% | 14.17% | -4.76% | 62.11% | - |
Gross Profit Gross Profit Growth | 9,846 | 9,846 | 9,407 | 7,918 | 7,406 | 4,529 |
Operating Income Operating Income Growth | 2,981 | 2,981 | 3,775 | 3,128 | 2,795 | 1,648 |
Net Income Net Income Growth | 1,747 | 1,747 | 2,724 | 2,169 | 1,935 | 1,223 |
Earnings Per Share EPS Growth | 19.25 | 19.25 | 30.04 | 23.93 | 21.35 | 13.49 |
EPS Growth | -35.92% | -35.92% | 25.53% | 12.08% | 58.27% | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
India India Growth | 8,689 | 7,819 | 11,520 |
Outside India Outside India Growth | 12,188 | 10,362 | 7,863 |
Unallocated Unallocated Growth | 273.76 | 345.14 | 69.74 |
Total Total Growth | 21,151 | 18,526 | 19,452 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 96.16 | 96.16 | 558.57 | 943.17 | 631.11 | 832.73 |
Total Debt Total Debt Growth | 7,937 | 7,937 | 4,208 | 2,853 | 2,153 | 3,414 |
Net Cash (Debt) Net Cash Growth | -7,841 | -7,841 | -3,650 | -1,909 | -1,522 | -2,581 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -86.40 | -86.40 | -40.24 | -21.07 | -16.79 | -28.48 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,619 | 2,619 | 3,316 | 2,164 | 2,501 | -437.04 |
Capital Expenditures CapEx Growth | -4,094 | -4,094 | -4,020 | -1,556 | -1,021 | -1,412 |
Free Cash Flow Free Cash Flow Growth | -1,474 | -1,474 | -704.76 | 607.5 | 1,480 | -1,849 |
Free Cash Flow Growth | - | - | - | -58.95% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 54.12% | 54.12% | 44.47% | 42.74% | 38.07% | 37.74% |
Operating Margin | 16.38% | 16.38% | 17.85% | 16.89% | 14.37% | 13.74% |
Pretax Margin | 12.80% | 12.80% | 17.05% | 16.22% | 13.41% | 12.95% |
Profit Margin | 9.60% | 9.60% | 12.88% | 11.71% | 9.95% | 10.19% |
FCF Margin | -8.10% | -8.10% | -3.33% | 3.28% | 7.61% | -15.40% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 3.500 | 3.500 | 5.000 | 3.000 | 2.000 |
Dividend Per Share Growth | 14.29% | -30.00% | 66.67% | 50.00% | - |
Dividend Yield | 0.52% | 0.59% | 0.67% | 0.70% | 0.73% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 34.66 | 30.72 | 24.93 | 18.17 | 12.92 | - |
P/FCF Ratio | - | - | - | 64.89 | 16.89 | - |
PS Ratio | 3.32 | 2.95 | 3.21 | 2.13 | 1.29 | - |